CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Shares withheld for taxes Huang Dennis Karl gave up 1,348 shares (to pay taxes)
- 4 Open-market sale SVP, Chief Accounting Officer sold 967 shares at $42.10 ($40,711)
- 4 Grant or award Chief Financial Officer acquired 15,653 shares (grant or award)
- 4 Open-market sale EVP and Chief Legal Officer sold 2,990 shares at an average $42.88 ($128,224)
- 4 Planned sale President & CEO sold 11,727 shares at $42.23 ($495,231)
- 4 Gift SVP, Chief Accounting Officer gave 648 shares (gift)
- 4 Planned sale President & CEO sold 8,273 shares at $50.00 ($413,650)
- 4 Open-market sale Chief Financial Officer sold 7,465 shares at $52.76 ($393,853)
- 4 Grant or award SVP, Chief Accounting Officer acquired 700 shares (grant or award)
- 4 Planned sale President & CEO sold 20,000 shares at $55.85 ($1,117,000)
- 4 Open-market sale SVP, Chief Accounting Officer sold 91 shares at $56.19 ($5,113)
- 4 Planned sale President & CEO sold 20,000 shares at $50.17 ($1,003,400)
- 4 Planned sale Director sold 584 shares at $40.98 ($23,932)
- 4 Grant or award Director acquired 5,345 shares (grant or award)
- 4 Grant or award Director acquired 5,345 shares (grant or award)
- 4 Grant or award Director acquired 5,345 shares (grant or award)
- 4 Grant or award Director acquired 5,345 shares (grant or award)
- 4 Grant or award Director acquired 5,345 shares (grant or award)
- 4 Grant or award Director acquired 5,345 shares (grant or award)
- 4 Grant or award Director acquired 5,345 shares (grant or award)
Page 4 of 32 · 627 filings